Skip to Content

251 (Pramipexole Dihydrochloride Extended-Release 0.375 mg)

Pill with imprint 251 is White, Round and has been identified as Pramipexole Dihydrochloride Extended-Release 0.375 mg. It is supplied by Par Pharmaceutical Inc.

Pramipexole is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.375 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 251

Pramipexole Dihydrochloride Extended-Release

Imprint:
251
Strength:
0.375 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Par Pharmaceutical Inc
National Drug Code (NDC):
10370-0251

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide